Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 20 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0000331 | contractile vacuole | 6 | 1 |
GO:0005773 | vacuole | 5 | 1 |
GO:0031410 | cytoplasmic vesicle | 6 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: A0A3S7XBZ8
Term | Name | Level | Count |
---|---|---|---|
GO:0043085 | positive regulation of catalytic activity | 4 | 2 |
GO:0043087 | regulation of GTPase activity | 5 | 2 |
GO:0043547 | positive regulation of GTPase activity | 6 | 2 |
GO:0044093 | positive regulation of molecular function | 3 | 2 |
GO:0050790 | regulation of catalytic activity | 3 | 2 |
GO:0051336 | regulation of hydrolase activity | 4 | 2 |
GO:0051345 | positive regulation of hydrolase activity | 5 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065009 | regulation of molecular function | 2 | 2 |
GO:0090630 | activation of GTPase activity | 7 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005096 | GTPase activator activity | 4 | 2 |
GO:0008047 | enzyme activator activity | 3 | 2 |
GO:0030234 | enzyme regulator activity | 2 | 2 |
GO:0030695 | GTPase regulator activity | 4 | 2 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 2 |
GO:0098772 | molecular function regulator activity | 1 | 2 |
GO:0140677 | molecular function activator activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 49 | 53 | PF00656 | 0.490 |
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.476 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.535 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.366 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.281 |
CLV_NRD_NRD_1 | 360 | 362 | PF00675 | 0.364 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.571 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.343 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.230 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.400 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.241 |
CLV_PCSK_KEX2_1 | 382 | 384 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.580 |
CLV_PCSK_PC1ET2_1 | 143 | 145 | PF00082 | 0.359 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.310 |
CLV_PCSK_PC1ET2_1 | 382 | 384 | PF00082 | 0.473 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 271 | 275 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 389 | 393 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.489 |
DEG_APCC_DBOX_1 | 348 | 356 | PF00400 | 0.394 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.730 |
DEG_SPOP_SBC_1 | 32 | 36 | PF00917 | 0.695 |
DOC_CKS1_1 | 64 | 69 | PF01111 | 0.484 |
DOC_MAPK_DCC_7 | 169 | 177 | PF00069 | 0.386 |
DOC_MAPK_MEF2A_6 | 169 | 177 | PF00069 | 0.377 |
DOC_MAPK_MEF2A_6 | 345 | 354 | PF00069 | 0.229 |
DOC_MAPK_MEF2A_6 | 389 | 396 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 391 | 397 | PF00149 | 0.427 |
DOC_PP2B_LxvP_1 | 84 | 87 | PF13499 | 0.580 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.280 |
DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.627 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.669 |
DOC_USP7_UBL2_3 | 267 | 271 | PF12436 | 0.217 |
DOC_USP7_UBL2_3 | 389 | 393 | PF12436 | 0.392 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.769 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.666 |
LIG_14-3-3_CanoR_1 | 178 | 183 | PF00244 | 0.321 |
LIG_14-3-3_CanoR_1 | 205 | 210 | PF00244 | 0.224 |
LIG_14-3-3_CanoR_1 | 360 | 366 | PF00244 | 0.468 |
LIG_14-3-3_CanoR_1 | 395 | 404 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 72 | 80 | PF00244 | 0.673 |
LIG_AP2alpha_1 | 94 | 98 | PF02296 | 0.359 |
LIG_APCC_ABBA_1 | 2 | 7 | PF00400 | 0.683 |
LIG_Clathr_ClatBox_1 | 354 | 358 | PF01394 | 0.337 |
LIG_deltaCOP1_diTrp_1 | 125 | 134 | PF00928 | 0.381 |
LIG_deltaCOP1_diTrp_1 | 252 | 259 | PF00928 | 0.397 |
LIG_eIF4E_1 | 286 | 292 | PF01652 | 0.227 |
LIG_eIF4E_1 | 326 | 332 | PF01652 | 0.371 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.323 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.711 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.311 |
LIG_FHA_1 | 367 | 373 | PF00498 | 0.414 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.434 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.540 |
LIG_FHA_2 | 365 | 371 | PF00498 | 0.308 |
LIG_GBD_Chelix_1 | 189 | 197 | PF00786 | 0.323 |
LIG_LIR_Gen_1 | 125 | 135 | PF02991 | 0.387 |
LIG_LIR_Gen_1 | 254 | 263 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 333 | 340 | PF02991 | 0.384 |
LIG_LIR_Gen_1 | 93 | 102 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 253 | 259 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 277 | 281 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 321 | 326 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 333 | 339 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 342 | 347 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.358 |
LIG_PCNA_PIPBox_1 | 296 | 305 | PF02747 | 0.394 |
LIG_Pex14_1 | 344 | 348 | PF04695 | 0.262 |
LIG_Pex14_2 | 274 | 278 | PF04695 | 0.365 |
LIG_Pex14_2 | 319 | 323 | PF04695 | 0.269 |
LIG_Pex14_2 | 94 | 98 | PF04695 | 0.339 |
LIG_PTB_Apo_2 | 262 | 269 | PF02174 | 0.422 |
LIG_PTB_Phospho_1 | 262 | 268 | PF10480 | 0.422 |
LIG_SH2_CRK | 176 | 180 | PF00017 | 0.252 |
LIG_SH2_GRB2like | 225 | 228 | PF00017 | 0.267 |
LIG_SH2_GRB2like | 326 | 329 | PF00017 | 0.371 |
LIG_SH2_GRB2like | 400 | 403 | PF00017 | 0.279 |
LIG_SH2_NCK_1 | 119 | 123 | PF00017 | 0.321 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.321 |
LIG_SH2_STAP1 | 314 | 318 | PF00017 | 0.229 |
LIG_SH2_STAT3 | 408 | 411 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.267 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 326 | 329 | PF00017 | 0.274 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.322 |
LIG_SH3_3 | 270 | 276 | PF00018 | 0.268 |
LIG_SUMO_SIM_anti_2 | 367 | 376 | PF11976 | 0.494 |
LIG_SUMO_SIM_par_1 | 361 | 370 | PF11976 | 0.420 |
LIG_TRAF2_1 | 103 | 106 | PF00917 | 0.423 |
LIG_TRAF2_1 | 35 | 38 | PF00917 | 0.538 |
LIG_UBA3_1 | 371 | 376 | PF00899 | 0.392 |
MOD_CDK_SPxK_1 | 63 | 69 | PF00069 | 0.637 |
MOD_CDK_SPxxK_3 | 63 | 70 | PF00069 | 0.471 |
MOD_CK1_1 | 16 | 22 | PF00069 | 0.611 |
MOD_CK1_1 | 208 | 214 | PF00069 | 0.454 |
MOD_CK1_1 | 364 | 370 | PF00069 | 0.317 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.610 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.410 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.539 |
MOD_CK2_1 | 364 | 370 | PF00069 | 0.393 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.447 |
MOD_GlcNHglycan | 397 | 400 | PF01048 | 0.515 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.618 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.611 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.702 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.280 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.274 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.311 |
MOD_NEK2_1 | 387 | 392 | PF00069 | 0.408 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.682 |
MOD_NEK2_2 | 318 | 323 | PF00069 | 0.276 |
MOD_PIKK_1 | 178 | 184 | PF00454 | 0.345 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.713 |
MOD_PK_1 | 205 | 211 | PF00069 | 0.202 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.538 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.786 |
MOD_PKA_2 | 305 | 311 | PF00069 | 0.251 |
MOD_Plk_1 | 197 | 203 | PF00069 | 0.433 |
MOD_Plk_2-3 | 33 | 39 | PF00069 | 0.544 |
MOD_Plk_4 | 241 | 247 | PF00069 | 0.282 |
MOD_Plk_4 | 318 | 324 | PF00069 | 0.275 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.769 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.667 |
MOD_SUMO_for_1 | 355 | 358 | PF00179 | 0.292 |
MOD_SUMO_rev_2 | 104 | 109 | PF00179 | 0.539 |
MOD_SUMO_rev_2 | 181 | 189 | PF00179 | 0.237 |
TRG_DiLeu_BaEn_1 | 358 | 363 | PF01217 | 0.276 |
TRG_DiLeu_BaEn_4 | 358 | 364 | PF01217 | 0.300 |
TRG_DiLeu_LyEn_5 | 358 | 363 | PF01217 | 0.286 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.283 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.264 |
TRG_ENDOCYTIC_2 | 326 | 329 | PF00928 | 0.332 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.538 |
TRG_ER_diArg_1 | 218 | 220 | PF00400 | 0.389 |
TRG_ER_diArg_1 | 360 | 362 | PF00400 | 0.319 |
TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.629 |
TRG_NES_CRM1_1 | 236 | 251 | PF08389 | 0.286 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3T4 | Leptomonas seymouri | 59% | 96% |
A0A0N1PDX9 | Leptomonas seymouri | 36% | 75% |
A0A0S4II34 | Bodo saltans | 36% | 97% |
A0A0S4ITU5 | Bodo saltans | 26% | 100% |
A0A1X0NLM2 | Trypanosomatidae | 44% | 100% |
A0A1X0NLQ9 | Trypanosomatidae | 43% | 97% |
A0A1X0P1K5 | Trypanosomatidae | 26% | 100% |
A0A3R7MIU7 | Trypanosoma rangeli | 32% | 100% |
A0A3S7XC15 | Leishmania donovani | 41% | 83% |
A0A422NJ84 | Trypanosoma rangeli | 41% | 99% |
A0A422NJE8 | Trypanosoma rangeli | 42% | 100% |
A4HQC6 | Leishmania braziliensis | 40% | 84% |
A4HQC7 | Leishmania braziliensis | 72% | 100% |
A4IE19 | Leishmania infantum | 41% | 83% |
A4IE20 | Leishmania infantum | 100% | 100% |
D0A3X9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 99% |
E9AU42 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9AU43 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q0F2 | Leishmania major | 93% | 100% |
Q4Q0F3 | Leishmania major | 36% | 100% |
Q6GLZ0 | Xenopus laevis | 32% | 100% |
Q8IV04 | Homo sapiens | 30% | 93% |
V5BT66 | Trypanosoma cruzi | 42% | 100% |